Likes Subject
Good morning, AVXL board! It has become glaringly IH Admin [Meghan] 11/03/22 11:59 AM
Here is a report given by Dr. Randi Hagerman. tradeherpete 04/02/22 8:03 AM
Money from vulture investors like LPC is expensive BIOChecker4 23 minutes ago
When a CEO is a poor communicator, the BIOChecker4 34 minutes ago
So what? Missling has managed the company's finances Steady_T 34 minutes ago
The market absolutely said it cannot stand the
ExtremelyBullishZig 38 minutes ago
Shove off. You are toast. No one actually ExtremelyBullishZig 42 minutes ago
Lol...welcome. Now you see what all my posts ExtremelyBullishZig 44 minutes ago
Apparently not. ExtremelyBullishZig 45 minutes ago
Neil Rebowe + the underwhelming cast of characters LarryMexico28 48 minutes ago
So, every doctor who has worked with the mike_dotcom 49 minutes ago
There was no rough water IMO - the Hoskuld 54 minutes ago
The market said nothing about AVXL today - Hoskuld 57 minutes ago
Not sure of the confusion. Anshu2 02/08/23 8:44 PM
Lol peeved 02/08/23 8:40 PM
Only the most delusional are expecting it to Anshu2 02/08/23 8:38 PM
Todays action was horrible peeved 02/08/23 8:32 PM
OK, let's not let some rough water screw nidan7500 02/08/23 8:24 PM
BTW - using the Lord's name in vain FitzyP33 02/08/23 8:18 PM
I'm sorry you refuse to see the truth George. FitzyP33 02/08/23 8:15 PM
RSBQ-AUC was such a huge SCAM! Unfortunately, I Anshu2 02/08/23 8:12 PM
I'm in favor of seeing the truth and FitzyP33 02/08/23 8:02 PM
Not really and covered under Safe Habor. Investor2014 02/08/23 8:00 PM
Just left whatever swipe filled in tbh, it $Money Bags$ 02/08/23 7:59 PM
I don’t think today’s action was bad — Anshu2 02/08/23 7:53 PM
I did not like today's trading too much! sab63090 02/08/23 7:49 PM
MIS-INFORMATION georgejjl 02/08/23 7:48 PM
Which investment bank would have their clients buy Anshu2 02/08/23 7:43 PM
No, it takes them 6 months to get Anshu2 02/08/23 7:37 PM
You are correct with pointing towards a more sab63090 02/08/23 7:37 PM
It is Rett syndrome NOT Rhett syndrome.
georgejjl 02/08/23 7:31 PM
georgejjl 02/08/23 7:24 PM
My guess is that due to all the Avx4L 02/08/23 7:21 PM
I think all of it in rides on $Money Bags$ 02/08/23 7:20 PM
Correction: georgejjl 02/08/23 7:14 PM
Hypothetically, if a company stated that their phase Avx4L 02/08/23 7:09 PM
I'll gladly take your shares... basparks79 02/08/23 7:09 PM
Missling is bad at communicating milestones, but he boi568 02/08/23 7:05 PM
“Did financing cause he knows they're won't be ignatiusrielly35 02/08/23 7:04 PM
Rather than trashing CM endlessly (yes, I am Anshu2 02/08/23 7:04 PM
Hope I'm wrong... basparks79 02/08/23 7:01 PM
Basparks - I would accept that, but ANVS avxllent 02/08/23 6:56 PM
NONSENSE!!! georgejjl 02/08/23 6:53 PM
This is just NOT TRUE!!!
georgejjl 02/08/23 6:51 PM
Fritzy’s post is accurate peeved 02/08/23 6:49 PM
Yes, the market has spoken and the whole basparks79 02/08/23 6:43 PM
Market Has Spoken. They Don't Like This Financing avxllent 02/08/23 6:40 PM
Anavex has made us a lot of money, basparks79 02/08/23 6:32 PM
When will you actually admit that peeved 02/08/23 6:30 PM
Where's the lie? They do have $140M basparks79 02/08/23 6:26 PM
You tell him, Mr. medical school lecturer. boi568 02/08/23 6:24 PM
George your boy Missling said new funding mrplmer 02/08/23 6:15 PM
Likes Subject

IH Admin [Meghan]
11/03/22 11:59 AM
04/02/22 8:03 AM
34 minutes ago
38 minutes ago
42 minutes ago
44 minutes ago
45 minutes ago
49 minutes ago
54 minutes ago
02/08/23 8:44 PM
02/08/23 8:40 PM
02/08/23 8:32 PM
02/08/23 8:24 PM
02/08/23 8:18 PM
02/08/23 8:15 PM
02/08/23 8:02 PM
02/08/23 8:00 PM
$Money Bags$
02/08/23 7:59 PM
02/08/23 7:48 PM
02/08/23 7:37 PM
02/08/23 7:37 PM
02/08/23 7:31 PM
02/08/23 7:24 PM
02/08/23 7:21 PM
$Money Bags$
02/08/23 7:20 PM
02/08/23 7:14 PM
02/08/23 7:09 PM
02/08/23 7:04 PM
02/08/23 7:01 PM
02/08/23 6:56 PM
02/08/23 6:53 PM
02/08/23 6:51 PM
02/08/23 6:49 PM
02/08/23 6:43 PM
02/08/23 6:32 PM
02/08/23 6:30 PM
02/08/23 6:26 PM
02/08/23 6:15 PM

Anavex Life Sciences Corp (AVXL)

Posts (Today)
Posts (Total)
Moderators RedShoulder Steady_T mrplmer 123tom kund mike_dotcom
Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052

Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer.  The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.

Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease.  ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.  Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others.  The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial.  ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.

The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.

Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL


Patent Info:

Clinical Trials:
Recent News:

Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

New Post